<p>(<b>A</b>) Representative examples for strong, moderate, weak and negative CPSF4 expression in lung adenocarcinoma tissues. Upper panels, ×40; lower panels, ×400, from the area of the box in upper panel respectively. (<b>B</b>) Comparison of CPSF4 expression levels between lung adenocarcinoma tissues and adjacent non-malignant lung tissues by immunohistochemistry in the same patient. Representative images of paired lung adenocarcinoma tissues and adjacent non-malignant lung tissues were shown (magnification, ×400).(<b>C</b>) ROC curve analysis was used to determine the cut-off score for high expression of CPSF4 protein in lung adenocarcinoma tissues. The sensitivity and specificity for OS were plotted; <i>p</i> = 0.002. (<b>D</b>) Kaplan...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
<p>According to the immunostaining intensity score and the percentage of positive cells, the results...
<p>(<b>A</b>) The expression of CPSF4 in human normal lung cell HBE and various lung adenocarcinoma ...
Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays a key role i...
<p>A: adenocarcinoma, S: squamous cell carcinoma, AS: adeno-squamous carcinoma, BAC: bronchioloalveo...
<p>Kaplan-Meier plots showing overall survival in lung adenocarcinoma. In red: patients with express...
ObjectivesAlthough the chemokine CXCL12 and its receptor CXCR4 have been implicated in metastasis of...
<p>(A): The expression pattern of BRF2 in lung cancer tissues. (a) High BRF2 expression in lung aden...
Lung cancer is a heterogeneous disease with varied outcomes. Molecular markers are eagerly investiga...
BackgroundIt has been proposed that the chemokine receptor, CXCR4, and its ligand, stromal cell-deri...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Background: The expression of CXCR4 has been implicated in metastatic dissemination in different mod...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
<p>According to the immunostaining intensity score and the percentage of positive cells, the results...
<p>(<b>A</b>) The expression of CPSF4 in human normal lung cell HBE and various lung adenocarcinoma ...
Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays a key role i...
<p>A: adenocarcinoma, S: squamous cell carcinoma, AS: adeno-squamous carcinoma, BAC: bronchioloalveo...
<p>Kaplan-Meier plots showing overall survival in lung adenocarcinoma. In red: patients with express...
ObjectivesAlthough the chemokine CXCL12 and its receptor CXCR4 have been implicated in metastasis of...
<p>(A): The expression pattern of BRF2 in lung cancer tissues. (a) High BRF2 expression in lung aden...
Lung cancer is a heterogeneous disease with varied outcomes. Molecular markers are eagerly investiga...
BackgroundIt has been proposed that the chemokine receptor, CXCR4, and its ligand, stromal cell-deri...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Background: The expression of CXCR4 has been implicated in metastatic dissemination in different mod...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
Lung adenocarcinoma is the most common subtype of lung cancer clinically, with high mortality and po...
<p>According to the immunostaining intensity score and the percentage of positive cells, the results...